Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis

Shock - United States
doi 10.1097/shk.0b013e3182168cce
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Effect of in Vivo Administration of Anti-Ctla-4 Monoclonal Antibody and IL-12 on the Induction of Low-Dose Oral Tolerance

Clinical and Experimental Immunology
AllergyImmunology
2002English

Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients

Science Translational Medicine
Medicine
2014English

The CTLA-4 Rs231775 GG Genotype Is Associated With Favorable 90-Day Survival in Caucasian Patients With Sepsis

Scientific Reports
Multidisciplinary
2018English

Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

An Anti-Cd154 Domain Antibody Prolongs Graft Survival and Induces Foxp3+iTreg in the Absence and Presence of CTLA-4 Ig

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2013English

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy

Pathology
Forensic MedicinePathology
2020English

Ctla-4 (Cd152)

Science-Business eXchange
2010English

Dose-Dependent Anti-Inflammatory Effect of Inhaled Mometasone Furoate/Formoterol in Subjects With Asthma

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy